HRMY vs. SCHD
HRMY (Harmony Biosciences Holdings, Inc.) is a stock, while SCHD (Schwab U.S. Dividend Equity ETF) is Dividend fund tracking the Dow Jones U.S. Dividend 100 Index. Over the past 5 years, HRMY returned -0.14%/yr vs 8.50%/yr for SCHD. At a 0.29 correlation, their price movements are largely independent.
Performance
HRMY vs. SCHD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HRMY achieves a -11.92% return, which is significantly lower than SCHD's 19.82% return.
HRMY
- 1D
- 2.68%
- 1M
- 1.92%
- YTD
- -11.92%
- 6M
- -13.83%
- 1Y
- -6.26%
- 3Y*
- -2.41%
- 5Y*
- -0.14%
- 10Y*
- —
SCHD
- 1D
- 0.68%
- 1M
- 2.84%
- YTD
- 19.82%
- 6M
- 19.65%
- 1Y
- 28.76%
- 3Y*
- 15.59%
- 5Y*
- 8.50%
- 10Y*
- 12.79%
HRMY vs. SCHD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
HRMY Harmony Biosciences Holdings, Inc. | -11.92% | 8.75% | 6.53% | -41.38% | 29.22% | 17.95% | -2.32% |
SCHD Schwab U.S. Dividend Equity ETF | 19.82% | 4.34% | 11.66% | 4.54% | -3.26% | 29.87% | 15.21% |
Correlation
The correlation between HRMY and SCHD is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.24 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.29 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.33 |
Correlation (All Time) Calculated using the full available price history since Aug 20, 2020 | 0.29 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HRMY vs. SCHD — Risk / Return Rank
HRMY
SCHD
HRMY vs. SCHD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Harmony Biosciences Holdings, Inc. (HRMY) and Schwab U.S. Dividend Equity ETF (SCHD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HRMY | SCHD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.79 | ||
| Sortino ratioReturn per unit of downside risk | -4.00 | ||
| Omega ratioGain probability vs. loss probability | 1.01 | 1.47 | -0.46 |
| Calmar ratioReturn relative to maximum drawdown | -0.18 | 6.26 | -6.44 |
| Martin ratioReturn relative to average drawdown | -0.33 | 15.38 | -15.71 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| HRMY | SCHD | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.15 | 2.64 | -2.79 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.00 | 0.59 | -0.60 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.77 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.04 | 0.86 | -0.90 |
Drawdowns
HRMY vs. SCHD - Drawdown Comparison
The maximum HRMY drawdown since its inception was -68.48%, which is greater than SCHD's maximum drawdown of -33.37%. Use the drawdown chart below to compare losses from any high point for HRMY and SCHD.
Loading charts...
Drawdown Indicators
| HRMY | SCHD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -68.48% | -33.37% | -35.11% |
Max Drawdown (1Y)Largest decline over 1 year | -34.49% | -4.61% | -29.88% |
Max Drawdown (3Y)Largest decline over 3 years | -50.81% | -16.13% | -34.68% |
Max Drawdown (5Y)Largest decline over 5 years | -68.48% | -16.85% | -51.63% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.37% | — |
Current DrawdownCurrent decline from peak | -45.89% | -0.73% | -45.16% |
Average DrawdownAverage peak-to-trough decline | -35.21% | -3.32% | -31.89% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.73% | 1.87% | +16.86% |
Volatility
HRMY vs. SCHD - Volatility Comparison
Harmony Biosciences Holdings, Inc. (HRMY) has a higher volatility of 10.38% compared to Schwab U.S. Dividend Equity ETF (SCHD) at 2.69%. This indicates that HRMY's price experiences larger fluctuations and is considered to be riskier than SCHD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HRMY | SCHD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.38% | 2.69% | +7.69% |
Volatility (6M)Calculated over the trailing 6-month period | 30.25% | 7.65% | +22.60% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.48% | 10.95% | +30.53% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 50.05% | 14.38% | +35.67% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 52.39% | 16.71% | +35.68% |
Dividends
HRMY vs. SCHD - Dividend Comparison
HRMY has not paid dividends to shareholders, while SCHD's dividend yield for the trailing twelve months is around 3.24%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HRMY Harmony Biosciences Holdings, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SCHD Schwab U.S. Dividend Equity ETF | 3.24% | 3.82% | 3.64% | 3.49% | 3.39% | 2.78% | 3.16% | 2.98% | 3.06% | 2.63% | 2.89% | 2.97% |
Frequently Asked Questions
HRMY and SCHD have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HRMY has higher volatility (10.38%) compared to SCHD (2.69%). In terms of maximum drawdown, HRMY dropped -68.48% vs SCHD's -33.37%.
SCHD currently has the higher Sharpe Ratio (2.64 vs -0.15), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HRMY and SCHD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer